DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV – Research Report) ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...

Key Takeaways U.S. equities continued their selloff on worries about the U.S economy possibly heading toward a ...

DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

On February 14, Travis Steed, an analyst at Bank of America Securities, maintained a Buy rating while keeping his price target of $84.09. DexCom, Inc. (NASDAQ:DXCM) has been growing its customer base.

it appears that whales have been targeting a price range from $60.0 to $120.0 for DexCom over the last 3 months. Insights into Volume & Open Interest Looking at the volume and open interest is a ...

Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. DexCom is up 9.9% during the same time and is ...